Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy.

CONTEXT Initiation of hormone replacement therapy (HRT) has been shown to increase breast density. Evidence exists that increased breast density decreases mammographic sensitivity. The effects on breast density of discontinuing and continuing HRT have not been studied systematically. OBJECTIVE To examine the effects of initiation, discontinuation, and continued use of HRT on breast density in postmenopausal women. DESIGN, SETTING, AND PARTICIPANTS Observational cohort study of 5212 naturally postmenopausal women aged 40 to 96 years and enrolled in a large health maintenance organization in western Washington State who had 2 screening mammograms between 1996 and 1998. MAIN OUTCOME MEASURES Breast density, assessed using the clinical radiologists' BI-RADS 4-point scale, compared among women who did not use HRT before either mammogram (nonusers); who used HRT before the first but not before the second mammogram (discontinuers); who used HRT before the second but not before the first mammogram (initiators); and who used HRT prior to both mammograms (continuing users). RESULTS Relative to nonusers, women who initiated HRT were more likely to show increases in breast density (relative risk [RR], 2.57; 95% confidence interval [CI], 2.12-3.08), while women who discontinued HRT use were more likely to show decreases in density (RR, 1.81; 95% CI, 1.06-2.98) and women who continued to use HRT were more likely to show both increases in density (RR, 1.33; 95% CI, 1.13-1.55) and sustained high density (RR, 1.45; 95% CI, 1.33-1.58). CONCLUSIONS These results indicate that breast density changes associated with HRT are dynamic, increasing with initiation, and decreasing with discontinuation.

[1]  P. Porter,et al.  Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. , 2000, Journal of the National Cancer Institute.

[2]  Anne M Kavanagh,et al.  Hormone replacement therapy and accuracy of mammographic screening , 2000, The Lancet.

[3]  B. V. VON Schoultz,et al.  Mammographic breast density during hormone replacement therapy: differences according to treatment. , 1999, American journal of obstetrics and gynecology.

[4]  J. Estève,et al.  Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme , 1999, Journal of medical screening.

[5]  J. Litherland,et al.  The effect of hormone replacement therapy on the sensitivity of screening mammograms. , 1999, Clinical radiology.

[6]  A. LaCroix,et al.  Are long-term hormone replacement therapy users different from short-term and never users? , 1999, American journal of epidemiology.

[7]  L W Bassett,et al.  Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. , 1999, Annals of internal medicine.

[8]  E. Wagner,et al.  Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  S. Taplin,et al.  Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. , 1996, Journal of the National Cancer Institute.

[10]  J. Gabrielsson,et al.  Pharmacokinetic data on estradiol in light of the estring concept. Estradiol and estring pharmacokinetics. , 1996, Acta obstetricia et gynecologica Scandinavica. Supplement.

[11]  E B Larson,et al.  Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. , 1995, Radiology.

[12]  M. Bracken,et al.  Clinically useful measures of effect in binary analyses of randomized trials. , 1994, Journal of clinical epidemiology.

[13]  A. Oza,et al.  Mammographic parenchymal patterns: a marker of breast cancer risk. , 1993, Epidemiologic reviews.

[14]  N. Boyd,et al.  The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. , 1992, Cancer detection and prevention.

[15]  M. Michell,et al.  The mammographic parenchymal patterns of women on hormonal replacement therapy. , 1991, Clinical radiology.

[16]  R N Hoover,et al.  Mammographic densities and risk of breast cancer , 1991, Cancer.

[17]  P. Stomper,et al.  Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. , 1990, Radiology.

[18]  J. Berkowitz,et al.  Hormonal replacement therapy: mammographic manifestations. , 1990, Radiology.

[19]  M. Szklo,et al.  Mammographic parenchymal patterns and breast cancer risk. , 1987, Epidemiologic reviews.

[20]  L. Gray,et al.  The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographic parenchymal patterns. , 1980, Cancer.